StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

CytoMed Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -1227.1%, against -3621.1% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1227.1%+2394.0
FY2024Dec 31, 2024-3621.1%–

More CytoMed Therapeutics figures

See a number that looks wrong?